Seed Media Group

Search this blog

Profile

Karen%27s%20headshot.JPG Hi there. I am a science/ medical writer based in Atlanta GA with a Ph.D. in cancer biochemistry from Emory University. The purpose of this blog is to write about current and interesting science news that may affect people's lives. I hope you enjoy my posts.

Science/Medical Writing
Jobs!


Brought to you by:

Hitt%20Medical%20Writing%20Logo.jpg

This Week's Featured Job:

Medical Writer, Cary, North Carolina

Medical education company seeks in-house medical writer to join content development team. Tasks include writing, research for new and ongoing programs, reference searches and retrievals, Med-Line searches, communication with faculty, and development of slides in PowerPoint.

Qualifications
Masters, PharmD, PhD or MD, with a medical or bioscience background
Please send resume, writing samples and salary requirements to

job2008@thecustomer.com

Subscribe to The HittListTM for more science/medical writing jobs!

make%20request%20image.jpg.jpg Is there a topic you would like me to write about? Send me your requests here.

thinkingbloggerpf8.jpg

BANNER%20NOTICE.jpg Submit your entries for the Science To Life Banner Contest! Email your entries to sci2life@aol.com or Click here.

Recent Posts

Recent Comments

Archives

Blogroll

Other Information

.

« Fighting superbugs | Main | Grilled meat and cancer? »

Fighting superbugs-part 2

Category: Health
Posted on: March 29, 2007 10:00 PM, by Karen Ventii

Yesterday I wrote about a research team that has developed a protein to fight antibiotic-resistant bacteria by boosting the immune system.

Now another research team from Rockefeller University has developed a modified viral protein called lysin to directly combat bacteria that thrive on a weakened immune system (such as that found in flu patients).

They have developed forms of lysin to target bacteria that cause middle ear infections, strep throat, pneumonia and meningitis.

The main idea here is to bypass the need to use antibiotics which run the more dangerous risk of producing antibiotic-resistant bacteria, aka superbugs.

Currently the research has been done in mice but human trials are expected to begin soon. Read more.

Post a Comment

(Email is required for authentication purposes only. Comments are moderated for spam, your comment may not appear immediately. Thanks for waiting.)





Having problems commenting? (UPDATED)

Blogs in the Network

Advertisement

Top Five: Readers' Picks

Search All Blogs